

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.04318573 |
| 2 | response to peptidoglycan (GO:0032494) | 5.79523251 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.70429963 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.70429963 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.70429963 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.70429963 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.70429963 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.70429963 |
| 9 | leukocyte aggregation (GO:0070486) | 5.31566741 |
| 10 | detection of bacterium (GO:0016045) | 5.16910566 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87182309 |
| 12 | neutrophil activation (GO:0042119) | 4.76663395 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.73956372 |
| 14 | granulocyte activation (GO:0036230) | 4.58384923 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.55936780 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.50074906 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.49981046 |
| 18 | * respiratory burst (GO:0045730) | 4.48914720 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.40267141 |
| 20 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.33730292 |
| 21 | response to host immune response (GO:0052572) | 4.31342237 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.31342237 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.27608445 |
| 24 | cellular extravasation (GO:0045123) | 4.22787814 |
| 25 | positive regulation of antigen processing and presentation (GO:0002579) | 4.20540272 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18523187 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.11882924 |
| 28 | response to muramyl dipeptide (GO:0032495) | 4.11582605 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10022177 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.07260043 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 4.04030908 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 4.02634237 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01657559 |
| 34 | response to host (GO:0075136) | 3.91090967 |
| 35 | response to host defenses (GO:0052200) | 3.91090967 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.91090967 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88579574 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.86294982 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.86294982 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 3.84193795 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 3.83925092 |
| 42 | detection of biotic stimulus (GO:0009595) | 3.83299815 |
| 43 | response to interleukin-15 (GO:0070672) | 3.81395301 |
| 44 | negative regulation of cell killing (GO:0031342) | 3.79088795 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.79088795 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.76715991 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 3.68768543 |
| 48 | * neutrophil mediated immunity (GO:0002446) | 3.67080892 |
| 49 | defense response to fungus (GO:0050832) | 3.66797062 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66383338 |
| 51 | * response to fungus (GO:0009620) | 3.63738842 |
| 52 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.61299726 |
| 53 | cellular response to zinc ion (GO:0071294) | 3.59626005 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 3.58226376 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.57759331 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.55865973 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.55501124 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52092985 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.51973660 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 3.51758143 |
| 61 | microglial cell activation (GO:0001774) | 3.50596988 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47613284 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40152527 |
| 64 | defense response to protozoan (GO:0042832) | 3.39968224 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.36733743 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 3.36109182 |
| 67 | B cell mediated immunity (GO:0019724) | 3.35042231 |
| 68 | negative regulation of interleukin-12 production (GO:0032695) | 3.34602690 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34505846 |
| 70 | neutrophil chemotaxis (GO:0030593) | 3.34173222 |
| 71 | negative regulation of phagocytosis (GO:0050765) | 3.33148027 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 3.32094138 |
| 73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.32094138 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 3.31786381 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31171393 |
| 76 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.30850900 |
| 77 | natural killer cell mediated immunity (GO:0002228) | 3.30850900 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 3.28512648 |
| 79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27539634 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24936974 |
| 81 | neutrophil migration (GO:1990266) | 3.24497980 |
| 82 | leukocyte cell-cell adhesion (GO:0007159) | 3.21778667 |
| 83 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.21643017 |
| 84 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.21643017 |
| 85 | regulation of growth of symbiont in host (GO:0044126) | 3.21643017 |
| 86 | negative regulation of growth of symbiont in host (GO:0044130) | 3.21643017 |
| 87 | germinal center formation (GO:0002467) | 3.20072961 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19309781 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 3.19130255 |
| 90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17962318 |
| 91 | macrophage activation (GO:0042116) | 3.16961343 |
| 92 | T-helper 1 type immune response (GO:0042088) | 3.16104962 |
| 93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15731899 |
| 94 | T cell migration (GO:0072678) | 3.14067833 |
| 95 | myeloid dendritic cell differentiation (GO:0043011) | 3.13379158 |
| 96 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.13213838 |
| 97 | * leukocyte mediated cytotoxicity (GO:0001909) | 3.10428762 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09898110 |
| 99 | regulation of tolerance induction (GO:0002643) | 3.09868433 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08416784 |
| 101 | response to protozoan (GO:0001562) | 3.07898263 |
| 102 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05750538 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04185980 |
| 104 | positive thymic T cell selection (GO:0045059) | 3.04074060 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04040628 |
| 106 | myeloid leukocyte activation (GO:0002274) | 3.02696918 |
| 107 | detection of other organism (GO:0098543) | 3.02436819 |
| 108 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01674506 |
| 109 | negative regulation of innate immune response (GO:0045824) | 3.00705740 |
| 110 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00345639 |
| 111 | leukocyte degranulation (GO:0043299) | 3.00332856 |
| 112 | negative thymic T cell selection (GO:0045060) | 2.99841181 |
| 113 | sequestering of metal ion (GO:0051238) | 2.99828771 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98306967 |
| 115 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98306967 |
| 116 | pinocytosis (GO:0006907) | 2.96979320 |
| 117 | negative regulation of interleukin-17 production (GO:0032700) | 2.96583047 |
| 118 | dendritic cell differentiation (GO:0097028) | 2.95656194 |
| 119 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.95314689 |
| 120 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95267553 |
| 121 | positive regulation of interferon-beta production (GO:0032728) | 2.94861408 |
| 122 | positive regulation of type 2 immune response (GO:0002830) | 2.94449691 |
| 123 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.94081814 |
| 124 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.93577463 |
| 125 | response to type I interferon (GO:0034340) | 2.90624880 |
| 126 | type I interferon signaling pathway (GO:0060337) | 2.90557214 |
| 127 | cellular response to type I interferon (GO:0071357) | 2.90557214 |
| 128 | negative regulation of interleukin-6 production (GO:0032715) | 2.90244929 |
| 129 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.88262121 |
| 130 | granulocyte migration (GO:0097530) | 2.87713603 |
| 131 | granulocyte chemotaxis (GO:0071621) | 2.87055054 |
| 132 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86797223 |
| 133 | macrophage differentiation (GO:0030225) | 2.85982018 |
| 134 | positive regulation of interleukin-12 production (GO:0032735) | 2.83493106 |
| 135 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81349933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.92663928 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.47837721 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.89693043 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.22294733 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.08420368 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.01033101 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.78723013 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.60067964 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.57917407 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.51408080 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.40797335 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00392314 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99261293 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.98356716 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.94507459 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.79536517 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.76550188 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.73644768 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.70033729 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.67985243 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63693898 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.58535223 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.39749710 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38496363 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33233327 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31258263 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21189394 |
| 28 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.16192743 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11853477 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.09000046 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06483420 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.03391199 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02894973 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.93630774 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90194541 |
| 36 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90184578 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88079167 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.85676063 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83724299 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.82848905 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76939030 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72619307 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70794790 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69173882 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63283762 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61360917 |
| 47 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59335431 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57011294 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54245392 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51780550 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44711935 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44128822 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39922521 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39527262 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39010843 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37863520 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35328989 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34194499 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31841923 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29609593 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28271091 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26335620 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24023232 |
| 64 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23933150 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23723703 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23596763 |
| 67 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22434980 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21112182 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21003792 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20427373 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17656495 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16582625 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.16304615 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15803659 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15431141 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15242457 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13612735 |
| 78 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09171939 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08999062 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08695092 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08539042 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08532921 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01797845 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00599244 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00525663 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99402517 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94040506 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90928952 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90780915 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88670215 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86774361 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86518888 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85439219 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85187697 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82561995 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81841164 |
| 97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81542671 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81223370 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81191204 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78770716 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.75993698 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74664215 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73453779 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71071703 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70334370 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.69921885 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.65383186 |
| 108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.65194509 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65028026 |
| 110 | P300_27268052_Chip-Seq_Bcells_Human | 0.63958339 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.63667745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.57610999 |
| 2 | MP0003303_peritoneal_inflammation | 4.25854577 |
| 3 | MP0003436_decreased_susceptibility_to | 3.94077009 |
| 4 | MP0009785_altered_susceptibility_to | 3.42563803 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.30786444 |
| 6 | MP0000685_abnormal_immune_system | 3.13884094 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.02267429 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.99905963 |
| 9 | MP0001790_abnormal_immune_system | 2.92451169 |
| 10 | MP0005387_immune_system_phenotype | 2.92451169 |
| 11 | MP0005025_abnormal_response_to | 2.91991470 |
| 12 | MP0001800_abnormal_humoral_immune | 2.80651635 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.77816308 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.77368356 |
| 15 | MP0006082_CNS_inflammation | 2.57858479 |
| 16 | MP0002723_abnormal_immune_serum | 2.56414084 |
| 17 | MP0005671_abnormal_response_to | 2.54358577 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.51088688 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.46244844 |
| 20 | * MP0001819_abnormal_immune_cell | 2.45572642 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.44641610 |
| 22 | MP0004510_myositis | 2.37596757 |
| 23 | MP0009278_abnormal_bone_marrow | 2.26770229 |
| 24 | MP0002405_respiratory_system_inflammati | 2.15648910 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.11241758 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.04002510 |
| 27 | MP0003724_increased_susceptibility_to | 2.03270547 |
| 28 | MP0001853_heart_inflammation | 1.95657944 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.91912181 |
| 30 | * MP0001845_abnormal_inflammatory_respons | 1.91571487 |
| 31 | MP0000716_abnormal_immune_system | 1.89865804 |
| 32 | MP0002398_abnormal_bone_marrow | 1.89539424 |
| 33 | MP0004947_skin_inflammation | 1.73821922 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.68494118 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.68494118 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.65314844 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.63281093 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.62918196 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.62222501 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.61100643 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.61096060 |
| 42 | MP0005310_abnormal_salivary_gland | 1.60560122 |
| 43 | MP0005451_abnormal_body_composition | 1.59122418 |
| 44 | MP0002429_abnormal_blood_cell | 1.57647598 |
| 45 | MP0002132_abnormal_respiratory_system | 1.56807954 |
| 46 | * MP0008469_abnormal_protein_level | 1.53211133 |
| 47 | MP0002722_abnormal_immune_system | 1.50635108 |
| 48 | MP0002006_tumorigenesis | 1.46828553 |
| 49 | MP0003075_altered_response_to | 1.46689900 |
| 50 | MP0003448_altered_tumor_morphology | 1.46472582 |
| 51 | MP0001873_stomach_inflammation | 1.45213892 |
| 52 | MP0001851_eye_inflammation | 1.43847647 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.42767023 |
| 54 | MP0009764_decreased_sensitivity_to | 1.38093914 |
| 55 | MP0000858_altered_metastatic_potential | 1.36666442 |
| 56 | * MP0000343_altered_response_to | 1.36178841 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.32420314 |
| 58 | MP0009840_abnormal_foam_cell | 1.29905699 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.28707814 |
| 60 | MP0010307_abnormal_tumor_latency | 1.26430659 |
| 61 | MP0002254_reproductive_system_inflammat | 1.25969670 |
| 62 | MP0004381_abnormal_hair_follicle | 1.13682324 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.13037314 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.10182441 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.08859346 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.06351686 |
| 67 | MP0002933_joint_inflammation | 1.06016148 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.04639986 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.03084496 |
| 70 | MP0000604_amyloidosis | 1.01136578 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.00194446 |
| 72 | MP0005166_decreased_susceptibility_to | 0.96725471 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.96082586 |
| 74 | MP0003828_pulmonary_edema | 0.95699187 |
| 75 | MP0000490_abnormal_crypts_of | 0.93747099 |
| 76 | MP0000703_abnormal_thymus_morphology | 0.93565320 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.92760199 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.92280870 |
| 79 | MP0008004_abnormal_stomach_pH | 0.88944491 |
| 80 | MP0005390_skeleton_phenotype | 0.88408766 |
| 81 | MP0008260_abnormal_autophagy | 0.85433814 |
| 82 | MP0003045_fibrosis | 0.84058889 |
| 83 | MP0000371_diluted_coat_color | 0.81324943 |
| 84 | * MP0009763_increased_sensitivity_to | 0.79848819 |
| 85 | * MP0004883_abnormal_blood_vessel | 0.79076388 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.77493454 |
| 87 | MP0003690_abnormal_glial_cell | 0.76016796 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.74301870 |
| 89 | MP0008874_decreased_physiological_sensi | 0.74261994 |
| 90 | MP0001663_abnormal_digestive_system | 0.73077098 |
| 91 | MP0003866_abnormal_defecation | 0.71708996 |
| 92 | MP0005023_abnormal_wound_healing | 0.69305629 |
| 93 | MP0001958_emphysema | 0.66204298 |
| 94 | * MP0000249_abnormal_blood_vessel | 0.65379098 |
| 95 | MP0003091_abnormal_cell_migration | 0.64778312 |
| 96 | MP0003795_abnormal_bone_structure | 0.63615740 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.63545720 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.63098136 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.62043232 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.61287782 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.55990870 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53283738 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.53045332 |
| 104 | * MP0005164_abnormal_response_to | 0.52440049 |
| 105 | MP0008057_abnormal_DNA_replication | 0.51823060 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.51792679 |
| 107 | MP0008873_increased_physiological_sensi | 0.51207257 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.50980737 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.48044555 |
| 110 | MP0000609_abnormal_liver_physiology | 0.47494856 |
| 111 | MP0005621_abnormal_cell_physiology | 0.46934713 |
| 112 | * MP0005319_abnormal_enzyme/_coenzyme | 0.46682094 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.46067935 |
| 114 | MP0000920_abnormal_myelination | 0.45889665 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 0.44627287 |
| 116 | MP0003186_abnormal_redox_activity | 0.43943974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 7.79046163 |
| 2 | * Recurrent bacterial skin infections (HP:0005406) | 6.86733241 |
| 3 | * Eczematoid dermatitis (HP:0000976) | 6.24518841 |
| 4 | * Recurrent gram-negative bacterial infections (HP:0005420) | 5.15442006 |
| 5 | * Abnormality of macrophages (HP:0004311) | 4.68797788 |
| 6 | * Recurrent skin infections (HP:0001581) | 4.51446545 |
| 7 | Myositis (HP:0100614) | 4.41243300 |
| 8 | * Mediastinal lymphadenopathy (HP:0100721) | 4.25388708 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.24633758 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.22391743 |
| 11 | * Recurrent fungal infections (HP:0002841) | 4.19374181 |
| 12 | * Chronic obstructive pulmonary disease (HP:0006510) | 4.11689335 |
| 13 | * Obstructive lung disease (HP:0006536) | 4.11689335 |
| 14 | Stomatitis (HP:0010280) | 4.02954603 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.98546510 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.96331206 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.87606795 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 3.84093830 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.78836859 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.78836859 |
| 21 | * Gingivitis (HP:0000230) | 3.76412223 |
| 22 | Recurrent viral infections (HP:0004429) | 3.72628716 |
| 23 | Orchitis (HP:0100796) | 3.56528812 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.55249756 |
| 25 | Vasculitis (HP:0002633) | 3.47109420 |
| 26 | Chronic otitis media (HP:0000389) | 3.41550409 |
| 27 | Hypochromic anemia (HP:0001931) | 3.41181222 |
| 28 | * Cellulitis (HP:0100658) | 3.40629212 |
| 29 | Periodontitis (HP:0000704) | 3.38032065 |
| 30 | * Meningitis (HP:0001287) | 3.33752898 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.26414040 |
| 32 | Optic neuritis (HP:0100653) | 3.26414040 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.13138547 |
| 34 | Pustule (HP:0200039) | 3.12799401 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10350458 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10350458 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10350458 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.09369918 |
| 39 | Disinhibition (HP:0000734) | 3.08764462 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 3.07744242 |
| 41 | Dysostosis multiplex (HP:0000943) | 3.05092013 |
| 42 | Colitis (HP:0002583) | 3.04093780 |
| 43 | Inflammation of the large intestine (HP:0002037) | 3.02209966 |
| 44 | Increased IgM level (HP:0003496) | 2.99283030 |
| 45 | Hematochezia (HP:0002573) | 2.91616408 |
| 46 | Episodic fever (HP:0001954) | 2.91016141 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.83861406 |
| 48 | * Urticaria (HP:0001025) | 2.80185119 |
| 49 | IgM deficiency (HP:0002850) | 2.78550296 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.77690464 |
| 51 | T lymphocytopenia (HP:0005403) | 2.77596364 |
| 52 | Anorexia (HP:0002039) | 2.76703111 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.75182800 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.74062776 |
| 55 | Glomerulonephritis (HP:0000099) | 2.72328976 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.71435015 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.70793649 |
| 58 | Leukocytosis (HP:0001974) | 2.69561772 |
| 59 | Abnormality of T cells (HP:0002843) | 2.67428891 |
| 60 | Pulmonary embolism (HP:0002204) | 2.64988158 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61860598 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.61860598 |
| 63 | Petechiae (HP:0000967) | 2.58648484 |
| 64 | Axonal loss (HP:0003447) | 2.58577222 |
| 65 | * Osteomyelitis (HP:0002754) | 2.56069575 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.54073294 |
| 67 | Basal ganglia calcification (HP:0002135) | 2.50787866 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49350962 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49350962 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49350962 |
| 71 | Increased IgE level (HP:0003212) | 2.48463319 |
| 72 | Agnosia (HP:0010524) | 2.47826481 |
| 73 | Microcytic anemia (HP:0001935) | 2.45486855 |
| 74 | Hemoptysis (HP:0002105) | 2.44486406 |
| 75 | Gingival bleeding (HP:0000225) | 2.44437963 |
| 76 | Thrombocytosis (HP:0001894) | 2.43603062 |
| 77 | Gangrene (HP:0100758) | 2.43037437 |
| 78 | Eosinophilia (HP:0001880) | 2.41905738 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.41481985 |
| 80 | Peritonitis (HP:0002586) | 2.40921442 |
| 81 | Premature loss of primary teeth (HP:0006323) | 2.40492325 |
| 82 | Purpura (HP:0000979) | 2.40187626 |
| 83 | Arterial thrombosis (HP:0004420) | 2.38364349 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.28639684 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.27078140 |
| 86 | Prostate neoplasm (HP:0100787) | 2.25915817 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.25660651 |
| 88 | Epistaxis (HP:0000421) | 2.25449264 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.24213896 |
| 90 | * Recurrent pneumonia (HP:0006532) | 2.22189341 |
| 91 | Restrictive lung disease (HP:0002091) | 2.21212416 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.21205613 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20573159 |
| 94 | Loss of speech (HP:0002371) | 2.19743282 |
| 95 | Chest pain (HP:0100749) | 2.18720416 |
| 96 | Increased serum ferritin (HP:0003281) | 2.17171042 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.16839603 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 2.16718908 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16111818 |
| 100 | Skin rash (HP:0000988) | 2.16047908 |
| 101 | Granulocytopenia (HP:0001913) | 2.15621187 |
| 102 | Glomerulopathy (HP:0100820) | 2.15572273 |
| 103 | * Skin ulcer (HP:0200042) | 2.15514265 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.15112882 |
| 105 | Abnormality of the endocardium (HP:0004306) | 2.14935788 |
| 106 | Lymphopenia (HP:0001888) | 2.14868489 |
| 107 | Nasal polyposis (HP:0100582) | 2.14529835 |
| 108 | Keratoconjunctivitis sicca (HP:0001097) | 2.14307278 |
| 109 | Thoracic kyphosis (HP:0002942) | 2.12443863 |
| 110 | Abnormality of the pericardium (HP:0001697) | 2.11516431 |
| 111 | Emphysema (HP:0002097) | 2.10355563 |
| 112 | Encephalitis (HP:0002383) | 2.09419810 |
| 113 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.09260055 |
| 114 | Panhypogammaglobulinemia (HP:0003139) | 2.07608633 |
| 115 | Recurrent bronchitis (HP:0002837) | 2.06438300 |
| 116 | Verrucae (HP:0200043) | 2.05836055 |
| 117 | Papilloma (HP:0012740) | 2.05836055 |
| 118 | Arthralgia (HP:0002829) | 2.05814783 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 2.02968480 |
| 120 | Keratitis (HP:0000491) | 1.99100642 |
| 121 | Cheilitis (HP:0100825) | 1.98335318 |
| 122 | Acne (HP:0001061) | 1.97164062 |
| 123 | * Sepsis (HP:0100806) | 1.96797901 |
| 124 | Thick nail (HP:0001805) | 1.95734882 |
| 125 | Osteolytic defects of the hand bones (HP:0009699) | 1.94819216 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94819216 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.93955706 |
| 128 | Amyloidosis (HP:0011034) | 1.92888519 |
| 129 | Myocardial infarction (HP:0001658) | 1.90796563 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89459384 |
| 131 | Abnormal platelet function (HP:0011869) | 1.89449997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.95217536 |
| 2 | MAP4K1 | 3.85712854 |
| 3 | BLK | 3.71788566 |
| 4 | MAP3K14 | 3.53279854 |
| 5 | TYK2 | 3.07374052 |
| 6 | TBK1 | 2.85560865 |
| 7 | KIT | 2.85517132 |
| 8 | IRAK3 | 2.63534922 |
| 9 | CSF1R | 2.47669276 |
| 10 | ERN1 | 2.23935366 |
| 11 | PRPF4B | 2.22975402 |
| 12 | EPHB1 | 2.21747875 |
| 13 | BTK | 2.14562650 |
| 14 | FES | 2.12276300 |
| 15 | IKBKE | 2.08917861 |
| 16 | IKBKB | 1.96272505 |
| 17 | TAOK1 | 1.94608940 |
| 18 | JAK3 | 1.88998424 |
| 19 | CSK | 1.87582860 |
| 20 | SYK | 1.87537940 |
| 21 | HCK | 1.72990385 |
| 22 | TEC | 1.72907428 |
| 23 | ZAP70 | 1.72309485 |
| 24 | JAK1 | 1.71992518 |
| 25 | MAP3K13 | 1.70578575 |
| 26 | STK10 | 1.67752764 |
| 27 | TGFBR2 | 1.54615951 |
| 28 | TAOK3 | 1.53843696 |
| 29 | TXK | 1.50232037 |
| 30 | MAP2K3 | 1.47954119 |
| 31 | CLK1 | 1.42568629 |
| 32 | GRK6 | 1.38945186 |
| 33 | FGR | 1.36724076 |
| 34 | LYN | 1.32970183 |
| 35 | FLT3 | 1.25422167 |
| 36 | * IRAK4 | 1.24890450 |
| 37 | MAP3K1 | 1.22576913 |
| 38 | LCK | 1.22129562 |
| 39 | RPS6KA4 | 1.15738328 |
| 40 | TAOK2 | 1.15382587 |
| 41 | LRRK2 | 1.13013533 |
| 42 | KSR2 | 1.13007312 |
| 43 | PIM1 | 1.12670147 |
| 44 | CHUK | 1.12487061 |
| 45 | ITK | 1.08860858 |
| 46 | SIK2 | 1.08129309 |
| 47 | MATK | 1.07632041 |
| 48 | SMG1 | 1.03907572 |
| 49 | JAK2 | 0.99230546 |
| 50 | PIM2 | 0.99035528 |
| 51 | CDK19 | 0.97175468 |
| 52 | TRPM7 | 0.96988543 |
| 53 | PRKD2 | 0.94953491 |
| 54 | TRIB3 | 0.94575161 |
| 55 | MARK3 | 0.94437783 |
| 56 | PTK6 | 0.94346140 |
| 57 | TTN | 0.93088664 |
| 58 | MARK2 | 0.89052108 |
| 59 | PAK4 | 0.88842691 |
| 60 | NEK9 | 0.84762039 |
| 61 | PKN2 | 0.81879740 |
| 62 | CAMK1D | 0.81180076 |
| 63 | STK4 | 0.78211657 |
| 64 | CDC42BPA | 0.76895303 |
| 65 | IRAK2 | 0.74588360 |
| 66 | MAP3K10 | 0.70624564 |
| 67 | TESK2 | 0.70120432 |
| 68 | FGFR3 | 0.63711488 |
| 69 | ALK | 0.63107682 |
| 70 | MAPK12 | 0.63040422 |
| 71 | SIK3 | 0.62546180 |
| 72 | EGFR | 0.60155653 |
| 73 | ABL1 | 0.58823030 |
| 74 | MAP3K11 | 0.55949643 |
| 75 | SIK1 | 0.55611960 |
| 76 | MAPKAPK2 | 0.55058527 |
| 77 | RPS6KA6 | 0.54887048 |
| 78 | MAPK7 | 0.54679020 |
| 79 | YES1 | 0.54471201 |
| 80 | HIPK2 | 0.53444313 |
| 81 | EPHA3 | 0.52809632 |
| 82 | PTK2B | 0.52143391 |
| 83 | STK11 | 0.51677354 |
| 84 | * PRKCD | 0.51626130 |
| 85 | RIPK1 | 0.51454916 |
| 86 | MAPK4 | 0.50834160 |
| 87 | PRKG2 | 0.48332791 |
| 88 | NEK2 | 0.48099625 |
| 89 | FGFR4 | 0.48068742 |
| 90 | MAP3K8 | 0.47482667 |
| 91 | CDK12 | 0.47271747 |
| 92 | MAP3K3 | 0.47204544 |
| 93 | DYRK1B | 0.46485167 |
| 94 | MAP3K7 | 0.45673595 |
| 95 | RPS6KL1 | 0.45194326 |
| 96 | RPS6KC1 | 0.45194326 |
| 97 | CAMK1G | 0.44633616 |
| 98 | DAPK2 | 0.44402034 |
| 99 | TESK1 | 0.43748307 |
| 100 | MAP3K6 | 0.43495525 |
| 101 | NME2 | 0.42956206 |
| 102 | CDK6 | 0.42817455 |
| 103 | EIF2AK2 | 0.42773527 |
| 104 | MAP2K4 | 0.42287623 |
| 105 | PRKCQ | 0.40636755 |
| 106 | SCYL2 | 0.39987212 |
| 107 | PDK1 | 0.39665835 |
| 108 | BMX | 0.37835941 |
| 109 | RPS6KA2 | 0.37565426 |
| 110 | GRK7 | 0.36944982 |
| 111 | CAMKK2 | 0.36478980 |
| 112 | FYN | 0.36159810 |
| 113 | MAP2K6 | 0.36046144 |
| 114 | RAF1 | 0.35360786 |
| 115 | MAP3K5 | 0.33397715 |
| 116 | BMPR2 | 0.32422549 |
| 117 | SGK3 | 0.32413734 |
| 118 | PRKCH | 0.32261347 |
| 119 | TNK2 | 0.32106537 |
| 120 | PBK | 0.31462094 |
| 121 | CAMKK1 | 0.31139233 |
| 122 | PDPK1 | 0.31057219 |
| 123 | MOS | 0.30538048 |
| 124 | MAP3K12 | 0.30227190 |
| 125 | ERBB3 | 0.30125889 |
| 126 | CDK4 | 0.27554177 |
| 127 | RET | 0.27445197 |
| 128 | PIK3CG | 0.27382188 |
| 129 | KSR1 | 0.27179157 |
| 130 | MAPK11 | 0.26748775 |
| 131 | ABL2 | 0.26274544 |
| 132 | IRAK1 | 0.25604481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.45163443 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.01554813 |
| 3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68029737 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.49103001 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.47639328 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46745259 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.27568953 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.26196706 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18436120 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.14340621 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12754233 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.08061739 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04551833 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.93866303 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93564744 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.87679498 |
| 17 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.86146295 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.83149060 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80313852 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75471449 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73894192 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73768114 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72854234 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.72123614 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68976849 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68353058 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.67434876 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.66675749 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58625502 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58262372 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.58093047 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.57730366 |
| 33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54977065 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.47075570 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46212005 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.44742647 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43752363 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.42945887 |
| 39 | * Phagosome_Homo sapiens_hsa04145 | 1.41552798 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36818060 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33196846 |
| 42 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32373655 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.24316405 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21333510 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14084318 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13493001 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12119112 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06575473 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00475732 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98611227 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97689349 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.97318130 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97053198 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96400469 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.95177882 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94464149 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94199892 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89437909 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89140450 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88959964 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88858632 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82457711 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80917209 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79738002 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.78355211 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77424722 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71123364 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66008030 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57241727 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56189616 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56047143 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53262456 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52724427 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49594980 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49332041 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.45191400 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45072549 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43904721 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43649347 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43023824 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41307238 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41232521 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39834685 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.39624917 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37987741 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37325681 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36974995 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35592807 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35553438 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34380106 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34230574 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34124690 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32673469 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.32479344 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30524406 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29566106 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29056591 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28658120 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28120567 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27969171 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27663365 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27644933 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26158965 |
| 104 | DNA replication_Homo sapiens_hsa03030 | 0.25446407 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25300215 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.24700370 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.24163337 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23339577 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22556479 |
| 110 | Base excision repair_Homo sapiens_hsa03410 | 0.20417658 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19885766 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18893642 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17631602 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.16487786 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16198698 |

